Pirtobrutinib for treating relapsed or refractory chronic lymphocytic leukaemia after a BTK inhibitor [ID6269]

  • In development
  • GID-TA11298
  • Expected publication date: 

Documents

Documents created during the development process.

Final draft guidance

Draft guidance

Declaration of interests

Committee meetings

  • Committee meeting

  • Committee meeting: 2

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Notes

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6269